BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 97 filers reported holding BRIDGEBIO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,197,066 | +128.0% | 45,395 | +44.3% | 0.00% | – |
| Q4 2021 | $525,000 | -94.0% | 31,467 | -83.1% | 0.00% | -100.0% |
| Q3 2021 | $8,739,000 | -4.2% | 186,438 | +24.6% | 0.00% | 0.0% |
| Q2 2021 | $9,121,000 | +83.9% | 149,649 | +85.9% | 0.00% | +50.0% |
| Q1 2021 | $4,959,000 | +113.5% | 80,506 | +146.4% | 0.00% | +100.0% |
| Q4 2020 | $2,323,000 | +132.1% | 32,671 | +6.4% | 0.00% | – |
| Q2 2020 | $1,001,000 | +0.5% | 30,700 | -10.6% | 0.00% | -100.0% |
| Q1 2020 | $996,000 | +255.7% | 34,339 | +330.0% | 0.00% | – |
| Q4 2019 | $280,000 | – | 7,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $373,797,000 | 67.28% |
| Darwin Global Management, Ltd. | 2,090,149 | $128,753,000 | 25.21% |
| Affinity Asset Advisors, LLC | 577,500 | $35,574,000 | 12.08% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,913,356,000 | 9.64% |
| Perceptive Advisors | 7,756,928 | $477,827,000 | 6.04% |
| Opaleye Management Inc. | 583,767 | $35,960,000 | 5.28% |
| MIZUHO MARKETS AMERICAS LLC | 171,923 | $10,590,000 | 4.93% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,639,853,000 | 4.88% |
| Fernwood Investment Management, LLC | 151,085 | $9,307,000 | 3.42% |
| HHLR ADVISORS, LTD. | 5,362,014 | $330,300,000 | 3.26% |